// App-Quantinova.ai

353 : Programmed death-ligand 1 characterization of circulating tumor cells and white blood cells in muscle-invasive and metastatic bladder cancer patients.

Researchers

Presenter

  • Terence W. Friedlander

Principal Investigators

  • David Lu

  • Rachel Krupa

  • Lawrence Fong

  • Ryan Vance Dittamore

  • Rosa Paz

  • Adam Jendrisak

  • Mark Landers

  • Jessica Louw

  • Sarah Orr

  • Dena Marrinucci

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved